Tokyo Tape
Sign in
← Torii Pharmaceutical

Annual report

4551.TEDINET S100QGWM
Period2022-01-01 → 2022-12-31
Filed2023-03-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 89
MetricValuePeriodScopeSource row
Revenue¥48.9bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥47.0bn2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥41.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥43.0bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥62.6bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥5.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income¥4.7bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income¥5.5bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥4.8bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income¥5.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.7bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.1bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥5.7bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥4.8bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥3.9bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥3.4bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income¥3.5bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥27.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥133.7bnat 2022-12-31StandaloneAssets
Total assets¥130.8bnat 2021-12-31StandaloneAssets
Total assets¥126.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥139.9bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥103.3bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥14.5bnat 2022-12-31StandaloneLiabilities
Total liabilities¥13.8bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥119.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥117.0bnat 2021-12-31StandaloneNet assets
Net assets / equity¥115.1bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥113.1bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥87.1bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥9.2bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.0bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥45.4bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥58.4bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥61.6bnat 2020-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥58.8bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥15.7bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥2.4bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥156m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥3.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥42.5bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥8.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥13.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥7.6bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥2.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥27.1bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥140.392022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥120.132021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥124.472020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥974.982019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥41.512018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥124.462020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥482021-01-01 → 2021-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥482020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482019-01-01 → 2019-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482018-01-01 → 2018-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,243.08at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,165.38at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,097.55at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,029.3at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,103.28at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio89.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.5%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.8%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE3.3%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE2.9%2021-01-01 → 2021-12-31StandaloneRate of return on equity (5-year summary)
ROE3.1%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE27.3%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
ROE1.3%2018-01-01 → 2018-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued28,800,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees563at 2022-12-31StandaloneNumber of employees
Employees560at 2021-12-31StandaloneNumber of employees
Employees568at 2020-12-31dStandaloneNumber of employees
Employees660at 2019-12-31dStandaloneNumber of employees
Employees1,049at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2022-12-31563 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 987
ItemContextValueUnit
Subtotal ope cfCurrentYearDuration_NonConsolidatedMember4094000000JPY
Interest and dividends income received ope cf inv cfPrior1YearDuration_NonConsolidatedMember328000000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration_NonConsolidatedMember345000000JPY
Interest expenses paid ope cf fin cfPrior1YearDuration_NonConsolidatedMember-0JPY
Interest expenses paid ope cf fin cfCurrentYearDuration_NonConsolidatedMember-0JPY
Payments for business structure restructuring expenses ope cfPrior1YearDuration_NonConsolidatedMember-11000000JPY
Payments for business structure restructuring expenses ope cfCurrentYearDuration_NonConsolidatedMember-12000000JPY
Income taxes paid refund ope cfPrior1YearDuration_NonConsolidatedMember21000000JPY
Income taxes paid refund ope cfCurrentYearDuration_NonConsolidatedMember-2006000000JPY
Net cash provided by used in operating activitiesPrior1YearDuration_NonConsolidatedMember-156000000JPY
Net cash provided by used in operating activitiesCurrentYearDuration_NonConsolidatedMember2420000000JPY
Purchase of short term investment securities inv cfPrior1YearDuration_NonConsolidatedMember-14900000000JPY
Purchase of short term investment securities inv cfCurrentYearDuration_NonConsolidatedMember-12309000000JPY
Proceeds from sales and redemption of securities inv cfPrior1YearDuration_NonConsolidatedMember18420000000JPY
Proceeds from sales and redemption of securities inv cfCurrentYearDuration_NonConsolidatedMember12100000000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration_NonConsolidatedMember-150000000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember-120000000JPY
Purchase of intangible assets inv cfPrior1YearDuration_NonConsolidatedMember-224000000JPY
Purchase of intangible assets inv cfCurrentYearDuration_NonConsolidatedMember-161000000JPY
Purchase of investment securities inv cfPrior1YearDuration_NonConsolidatedMember-9376000000JPY
Purchase of investment securities inv cfCurrentYearDuration_NonConsolidatedMember-19136000000JPY
Proceeds from sales and redemption of investment securities inv cfPrior1YearDuration_NonConsolidatedMember5360000000JPY
Proceeds from sales and redemption of investment securities inv cfCurrentYearDuration_NonConsolidatedMember5564000000JPY
Payments for investments in capital inv cfPrior1YearDuration_NonConsolidatedMember-200000000JPY
Payments for investments in capital inv cfCurrentYearDuration_NonConsolidatedMember－JPY
Other net inv cfPrior1YearDuration_NonConsolidatedMember-426000000JPY
Other net inv cfCurrentYearDuration_NonConsolidatedMember385000000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-1498000000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-13676000000JPY
Purchase of treasury stock fin cfPrior1YearDuration_NonConsolidatedMember-0JPY
Purchase of treasury stock fin cfCurrentYearDuration_NonConsolidatedMember-0JPY
Cash dividends paid fin cfPrior1YearDuration_NonConsolidatedMember-1348000000JPY
Cash dividends paid fin cfCurrentYearDuration_NonConsolidatedMember-1348000000JPY
Repayments of lease obligations fin cfPrior1YearDuration_NonConsolidatedMember-198000000JPY
Repayments of lease obligations fin cfCurrentYearDuration_NonConsolidatedMember-348000000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember-1546000000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember-1698000000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-3201000000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember-12954000000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember61576000000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember58374000000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember58374000000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember45420000000JPY
Write downs of inventoriesPrior1YearDuration_NonConsolidatedMember-79000000JPY
Write downs of inventoriesCurrentYearDuration_NonConsolidatedMember-114000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember832000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember1661000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass